Ratings by Evercore ISI (Daniel Markowitz)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/27/2026 | Inspire Medical Systems | INSP | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2026 | Insulet Corporation | PODD | Maintain | Outperform (N/A) |
|
Details | ||
| 1/22/2026 | Inspire Medical Systems | INSP | Maintain | Outperform (N/A) |
|
Details | ||
| 12/16/2025 | Insulet Corporation | PODD | New Coverage | Outperform (N/A) |
291.51 (237.01) |
-18.7% | Details | |
| 11/25/2025 | DexCom | DXCM | New Coverage | In Line (N/A) |
62.21 (68.10) |
9.47% | Details | |
| 11/7/2025 | Natera | NTRA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/27/2025 | West Pharmaceutical | WST | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2025 | West Pharmaceutical | WST | Maintain | Outperform (N/A) |
|
Details | ||
| 9/22/2025 | Regency Centers | RGEN | Upgrade | Outperform (In Line) |
70.27 (119.99) |
70.76% | Details | |
| 9/16/2025 | TransMedics Group | TMDX | New Coverage | Outperform (N/A) |
114.29 (129.61) |
13.4% | Details | |
| 9/4/2025 | Guardant Health | GH | Maintain | Outperform (N/A) |
|
Details | ||
| 9/2/2025 | Inspire Medical Systems | INSP | New Coverage | Outperform (N/A) |
93.69 (62.99) |
-32.77% | Details | |
| 7/28/2025 | Natera | NTRA | New Coverage | Outperform (N/A) |
138.90 (198.13) |
42.64% | Details | |
| 7/24/2025 | West Pharmaceutical | WST | Maintain | Outperform (N/A) |
|
Details | ||
| 7/14/2025 | Guardant Health | GH | Maintain | Outperform (N/A) |
|
Details | ||
| 7/8/2025 | Repligen | RGEN | Maintain | In Line (N/A) |
|
Details | ||
| 3/18/2025 | West Pharmaceutical | WST | New Coverage | Outperform (N/A) |
230.11 (245.86) |
6.84% | Details | |
| 3/18/2025 | Bio-Techne Corp. | TECH | New Coverage | Outperform (N/A) |
62.16 (53.89) |
-13.3% | Details | |
| 3/18/2025 | Repligen | RGEN | New Coverage | In Line (N/A) |
150.62 (119.99) |
-20.34% | Details |
